ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

March 3, 1989

Clinical Trials Approved By NCI

November 28, 2003

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

NCI contract Award

August 1, 1997

Healy, Kessler Lose Jobs In Last-Minutes Maneuver By Bush White House To Defy Clinton Request

January 22, 1993

In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst.

May 13, 1994